Predictive Parameters of a Worse Prognosis in Patients with G2 Neuroendocrine Tumors Treated with Peptide Radio Receptorial Therapy

被引：0
|
作者：
Jandric, J. [1 ]
Laffi, A. [1 ]
Muraglia, L. [1 ]
Zanca, R. [1 ,2 ]
Rodari, M. [1 ]
Evangelista, L. [1 ,2 ]
机构：
[1] IRCCS Humanitas Res Hosp, Rozzano, Italy
[2] Humanitas Univ, Pieve Emanuele Milano, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0598
引用
收藏
页码：S669 / S670
页数：2
相关论文
共 50 条
  • [21] Prognostic Role of Diabetes Mellitus (DM) and Metformin (MET) Therapy in Patients (pts) with Advanced G1-G2 Neuroendocrine Tumors (NETs) Treated with Everolimus (EVE)
    Custodio, A.
    Jimenez-Fonseca, P.
    Alonso-Orduna, V
    Lopez Lopez, C.
    Alonso, T.
    Crespo, G.
    Carmona-Bayonas, A.
    Alvarez-Escola, C.
    Solis, M. P.
    Capdevila, J.
    Feliu, J.
    Aller, J.
    Grande, E.
    Barriuso, J.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 129 - 130
  • [22] Resection of the Primary Tumors Prolonged the Overall and Progression Free Survival in Patients with Neuroendocrine Neoplasms Stage IV Treated by Peptide Radionuclide Therapy (PRRT)
    Kaemmerer, Daniel
    Twiznik, Matthias
    Kulkrani, Harshad R.
    Hoersch, Dieter
    Sehner, Susanne
    Baum, Richard
    Hommann, Merten
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 192 - 192
  • [23] Patients with Advanced Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy with 177Lu-DOTATE: Data from Spanish SEPTRALU Registry
    Mitjavila, M.
    Percovich, J. C.
    Pombo Pasin, M. C.
    Bello, P.
    Arbizu, J.
    Llana, B.
    Riesco, M. C.
    Muros, M. A.
    Estenoz, J.
    Rotger, A.
    Aller, J.
    Jimenez-Fonseca, P.
    NEUROENDOCRINOLOGY, 2019, 108 : 223 - 223
  • [24] THE RELATIONSHIP BETWEEN TUMOUR DOSIMETRY AND OTHER PREDICTIVE AND PROGNOSTIC FACTORS IN PATIENTS WITH UNRESECTABLE NEUROENDOCRINE NEOPLASM (NEN) TREATED WITH PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT)
    Alipour, Ramin
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 31 - 31
  • [25] Everolimus (EVE)-Induced Hyperglycemia (HG) in Patients (pts) with Advanced G1-G2 Neuroendocrine Tumors (NETs): Clinical Relevance and Predictive Value
    Custodio, A.
    Jimenez-Fonseca, P.
    Alonso-Orduna, V
    Lopez Lopez, C.
    Alonso, T.
    Guillermo, C.
    Carmona-Bayonas, A.
    Alvarez-Escola, C.
    Solis, M. P.
    Capdevila, J.
    Grande, E.
    Barriuso, J.
    Feliu, J.
    Aller, J.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 130 - 130
  • [26] Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection
    Lv, Yang
    Han, Xu
    Xu, Xue-Feng
    Ji, Yuan
    Zhou, Yu-Hong
    Sun, Hui-Chuan
    Zhou, Jian
    Fan, Jia
    Lou, Wen-Hui
    Huang, Cheng
    BMC CANCER, 2019, 19 (1)
  • [27] Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection
    Yang Lv
    Xu Han
    Xue-Feng Xu
    Yuan Ji
    Yu-Hong Zhou
    Hui-Chuan Sun
    Jian Zhou
    Jia Fan
    Wen-Hui Lou
    Cheng Huang
    BMC Cancer, 19
  • [28] Risk Factors Affecting Prognosis in Metachronous Liver Metastases from WHO Classification G1 and G2 Gastroenteropancreatic Neuroendocrine Tumors after Initial R0 Surgical Resection
    Lyu, Y.
    Han, X.
    Xu, X.
    Ji, Y.
    Zhou, Y.
    Sun, H.
    Zhou, J.
    Fan, J.
    Lou, W.
    Huang, C.
    NEUROENDOCRINOLOGY, 2018, 106 : 98 - 98
  • [29] Characteristics of Pancreatic Neuroendocrine Tumors (PNET) patients treated with Peptide Receptor Radionuclide Therapy (PRRT) in two Canadian centers - A real-world evidence study
    Tsvetkova, E.
    Welch, S.
    Laidley, D.
    Sachdeva, R.
    Goodwin, R.
    Nair, G.
    Leung, M.
    Asmis, T.
    Phillips, W.
    Black, M.
    Vickers, M.
    Marginean, H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 209 - 209
  • [30] Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases
    Bertani, Emilio
    Fazio, Nicola
    Radice, Davide
    Zardini, Claudio
    Grana, Chiara
    Bodei, Lisa
    Funicelli, Luigi
    Ferrari, Carlo
    Spada, Francesca
    Partelli, Stefano
    Falconi, Massimo
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S981 - S989
12345